{"title": "PDF", "author": "PDF", "url": "mn.gov/boards/assets/ADA_Patient_Return_Talking_About_Vaccines_tcm21-508634.pdf", "hostname": "PDF", "description": "PDF", "sitename": "PDF", "date": "PDF", "id": "PDF", "license": "PDF", "body": "PDF", "comments": "PDF", "commentsbody": "PDF", "raw_text": "PDF", "text": " \nLast Updated: 6/29/2021     1 \nPatient Return : Talking with Your \nPatients About COVID -19 Vaccines  \nThe Biggest Public Health Opportunity  of Our Time\nHealth and safety have  been top priority throughout the pandemic, and dentists have played an important role  \nin reducing the risk of COVID -19 and building patient confidence in dental visits. According to the ADA Health Policy \nInstitute, 93% of consumers have recently been to a dental visit or ready to go. Those who have not returned are \nwaiting for COVID -19 vacc ines and medical breakthroughs.  \nNow,  we have vaccines that can prevent COVID -19. Just as dentists and their teams built patient confidence around \ndental visits, they can also play an influential role as trusted health advisors for their patients when discu ssing \nCOVID -19 vaccines. Research indicates those who are hesitant about receiving the vaccine may become more \nconfident after discussing it with healthcare professionals they know and trust.  \nThe ADA, in collaboration with the Centers for Disease Control and Prevention (CDC) and other national health \nagencies, is working to help improve vaccine confidence , protect the public\u2019s health and end COVID -19. We invite  \nyou and your dental teams to join us by using this suite of patient communication tools.   \n \n \nTable of Contents   \nPage 2    Conversation Starters: Ways to Engage Your Patients  \nTalking points and tips to help you bring up the subject of vaccination and communicate  \neffectively with pa tients.   \nPage 4    Your Team\u2019s Vaccination Status  \nBecause dentists and dental teams have been prioritized to receive the COVID -19 vaccine,  \nyour patients may ask if you and your team have been vaccinated. Here\u2019s what you can  \nand shouldn\u2019t say.  \nPage 5    Take -Home  Fact Sheets  (English and Spanish)  \nThese easy -to-read sheets provide vaccine information from the CDC and other medical experts.  \nPage 6    Frequently Asked Questions  (English and Spanish)    \nUse this comprehensive FAQ to reassure patients with sample responses that address potential patient \nconcerns. These answers can be used during phone calls, in email exchanges or on social media.  \nPage 18    Emails  (English and Spanish)  \nGet three unique messages you can use to reach out to patients. All can be customized to  \nfit your practice\u2019s needs.  \nPage 24    In-Office  Signs  (English and Spanish)  \nDownload five options to display in waiting rooms, exam rooms or near your reception desk.  \nPage 25    Suggestions for Social Media   \nUse these tips to create simple messages you can share on your social media channels.  \nPage 26    Additional Resources  \nLooking for additional information? Here are some key resources from the ADA and other  \nhealth organizations.  \n   \n \n      Last Upda ted: 6/29/2021     2 \nPatient Return : Talking with Your \nPatients About COVID -19 Vaccines  \nConversation Starters: Ways to Engage Your Patients  \nAs the pandemic continues, people are curious and concerned about COVID -19 vaccines and their value in \npreventing illness. Here are strategies and tips to help you and your team bridge these conversation s with patients.  \n \nStarting the conversation  \nInclude vaccination as part of your COVID -19 screening questions, or when you\u2019re discussing a patient\u2019s \nhealth history.  These are natural times to uncover concerns or questions your patients may have.  \nConnect wh y you and your team are discussing the COVID -19 vaccine during a dental visit.   \nHere\u2019s a sample script to use when starting the conversation:  \nThroughout the COVID -19 pandemic, our dental team has put your health and safety first by  \n taking extra steps to h elp prevent the spread of the virus in our office.  \nWe appreciate the way you\u2019ve helped keep our team healthy by wearing masks to your  \nappointments, answering screening questions and following our new waiting room procedures.  \nNow, the availability of COV ID-19 vaccines gives us one more important tool to keep each other  \nsafe. As a health care professional, I\u2019m happy to talk to you about COVID -19 vaccination.  \n \nAsk simple questions , and make them open -ended when possible . A few examples include:  \n\u201cWhen are  you planning to get your COVID -19 vaccination?\u201d  \n\u201cWhat have you heard about the vaccine?\u201d  \n\u201cWhat questions do you have ?\u201d \n\u201cWould you be interested in taking home a fact sheet to learn more about the vaccine?\u201d  \n\u201cDo you know where you can be vaccinated ?\u201d \n \nImportant Conversation Considerations  \nEmphasize your concern for their overall health.  \u201cAs a dentist, I care for your oral and overall health. COVID -19 is \na major concern for all of us, so I wanted to bring it up today.\u201d   \nProvide facts on vaccine safety an d effectiveness.  Often times, people are more receptive to information if it is \ndelivered by a trusted messenger, even if they\u2019ve come across the same information elsewhere. Your patients want to \nknow what you think and may trust the information you share with them because it came from you.  \nConsider sharing your own vaccination story.  Sometimes, what matters more than the message is the \nmessenger. Mention that you\u2019ve been vaccinated and share any details that seem helpful. If they so choose, y our \nteam  may do the same.  \n  \n \n      Last Upda ted: 6/29/2021     3 \nPatient Return : Talking with Your \nPatients About COVID -19 Vaccines  \nRespect that patient opinions vary , and approach the conversation with empathy . People from many walks of \nlife have different concerns around the virus  and vaccination s in general , so it is important to listen and realize this \nwon\u2019t be a \u201cone -size-fits-all\u201d conversation. Some people may have medical considerations , religious beliefs or \nphilosophical beliefs that may be a factor in their decision to get vaccinated. Factors such as a person\u2019s age, where \nthey live, their level of education, race,  and political affiliation may impact their decision -making process . As always, \nshowing concern and respect for individual situations is essential.  \nBe prepared to have the vaccine conversation multiple times with the same patient.  Your patients who are \nhesitant about the vaccine may not have completely ruled out getting it. They may be taking a \u201cwait and see\u201d \napproach as they hear more experiences from others and safety data continues to be collected nationwide. Make a \nnote to check -in with patients during  their next visit to gauge how their perceptions may have changed since you last \nsaw them.  \n \nAdditional Conversation Resources  \no The CDC has a five -step guide to having an effective conversation about the COVID -19 vaccine.  \nRead and share with your team.   \no Join the U.S. Department of Health and Human Ser vices' COVID -19 Community Corps. Download \nconversation guides, fact sheets and more.  \no Watch the ADA's free recorded webinar \"Let's Talk Shots! Effective Patient Conversations About the  \nCOVID -19 Vaccine\"  with your team. Earn 1 CE credit.  \n   \n \n      Last Upda ted: 6/29/2021     4 \nPatient Return : Talking with Your \nPatients About COVID -19 Vaccines  \nWhat to Say When a Patient Asks If Your Team Has Been Vaccinated  \nADA strongly advocated for d entists  and dental teams to be  prioritize d as 1a  by the CDC when vaccine  \ndistribution began in December 2020. Because of this, you and some of your team may already be fully vaccinated , \nand patients may be asking for a number of different reasons. Use these considerations to help guide the \nconver sation in a way that educates the patient but also protects you and your team:  \n \nProtect your team\u2019s privacy.  \nOffices have an obligation to protect everyone\u2019s health information \u2014 patients and staff. There may be cases where \nyou or a team member cannot rec eive the vaccine for medical, religious or protected philosophical differences. If \nasked about your team\u2019s vaccination status, a simple response is, \u201cI can share that everyone on our staff has been \nvery excited about the vaccine roll out.\u201d If asked to provide further information, the dentist should decline, citing \nprivacy reasons.  \n \nSharing is voluntary.  \nIf you have personally received the vaccine and are open to sharing, communicate relevant points that can help \neducate your patient about the experienc e, including where you went, what the process was like and how you felt \nafter. This could be an impactful conversation for a patient who is hesitant about the vaccine.  Team members who \nwant to share their experiences can, but only if it is their choice. Le ave the decision up to them.  \n \nReinforce the importance of infection control.  \nRemind your patients and team that the vaccine protects the person who got it, and that we still don\u2019t know if those \nwho are vaccinated can still spread the virus to others. This is a wonderful opportunity to talk about what really \nmatters for the health a nd safety of your patients, your team and you is continuing to follow strict infection control \nprotocols. Vaccinations are what will help with the much larger scale effort of stopping the spread of this pandemic.  \nPatient communication materials to help gu ide infection control conversations are available at ADA.org/ Patient Return . \n \nFoster an office culture of respect.   \nAn employe r can have private conversation s with employee s to learn  if they have received the vaccine, but there \nshould not be prob ing for the \u201cwhy\u201d behind an employee\u2019s reason for not being vaccinated unless the employee \nchooses to volunteer that information.  As the  leader of your dental team, foster a culture of respect and step in if you \nobserve any type of pressure between team members about being  vaccinate d. Remind them that office infection \ncontrol measures are  most important and is something everyone can do to keep one another safe. Read more about \nlegal issues in these employer vaccination FAQs  and employee vaccination FAQs . \n   \n \n      Last Upda ted: 6/29/2021     5 \nPatient Return : Talking with Your \nPatients About COVID -19 Vaccines  \nTake -Home Fact Sheets  \nDownload and share these printable sheets with your patients.  \n \n \nDOWNLOAD:   \nCDC COVID -19 Vaccine  \nFact Sheet (English)  \nCDC COVID -19 Vaccine  \nFact Sheet (Spanish)  \n \nDownload this easy -to-read, two -page \ninformation sheet from the CDC\u2019s \nwebsite.  \n  \nDOWNLOAD:   \nPregnancy and the COVID -19 Vaccine  \n(English)  \nPregnancy and the COVID -19 Vaccine  \n(Spanish)  \n \nShare this information with patients \nwho are pregnant or considering \npregnancy.   \nDOWNLOA D & CUSTOMIZE :  \nCOVID -19 Vaccine:  \nFact vs. Fiction  (English)  \nCOVID -19 Vaccine:  \nFact vs. Fiction ( Span ish) \n \nHelp correct misconceptions and \ncustomize with information about \nwhere patients can access the   \nvaccine in your area.  \n \n \n \n \n \n  \n \n \n      Last Upda ted: 6/29/2021     6 \nPatient Return : Talking with Your \nPatients About COVID -19 Vaccines  \nFrequently Asked Questions  \nUse these sample responses to help answer common questions you and your team may receive from patients during \na conversation . Feel free also to use these in additional communications, such as phone conversations, emails or \nsocial media responses.   \n \nPreguntas frecuentes  \nUtilice estos ejemplos de respuestas para ayudar a responder preguntas comunes que usted y su equipo \npueden recibir de los pacientes durante una conversaci\u00f3n. No dude en utilizarlos tambi\u00e9n en comunicaciones \nadicionales, como conversa ciones telef\u00f3nicas, correos electr\u00f3nicos o respuestas en redes sociales.  \n \n \nHow was this vaccine developed so quickly?  \nThe speed that enabled this vaccine to be developed and ready for use  in less than one year is due to three \nmain factors:  \n\u2022 The type of vac cine being used  \n \nmRNA Vaccines (Pfizer and Moderna)  \no The genetic sequence of the virus was widely available in January  2020 , allowing scientists to rapidly \ndevelop vaccines . The vaccines  began  early stage  clinical trials even before the virus reached \npandemic levels.  \no Another advantage of mRNA vaccines is there is no possibility that they can contain any live virus.  \no Here\u2019s how  mRNA vaccines work : When injected, the mRNA t ells your body  how to make a spike \nprotein found on the outside of the virus. Your body responds to that protein  as an enemy  and \ndefends itself by producing antibodies. (Antibodies are proteins that attach to proteins on the outside \nof viruses . They  coordinate the effort to eliminate the vir us from your body .) Then, cells in your body \nremember that enemy  and can produce those antibodies in the future if you need them .  \no The technology to produce mRNA vaccine s has been around more than 10 years .  \n \nViral Vector Vaccines (Johnson & Johnson)  \no The w ay the Johnson & Johnson\u2019s vaccine teaches your body how to fight the virus is similar to the \nmRNA vaccine but has a different starting point.  Instead of injecting already -produced mRNA, this \nvaccine prompts your body to make  the mRNA on its own .  \no This type of vaccine  adds DNA for COVID -19\u2019s spike protein to  the double -stranded DNA  of the virus . \nIt is a weakened virus that won\u2019t make you sick.   \no The weakened virus  \u2014 which includes DNA from  the spike protein  \u2014 enters the center of the cell, \ncalled the  nucleus. The cell responds by making mRNA for the spike protein.   \n \n \n      Last Upda ted: 6/29/2021     7 \nPatient Return : Talking with Your \nPatients About COVID -19 Vaccines  \no From there, like the other COVID -19 vaccines, the spike protein exits the cell and stimulates the \nimmune response.  \n\u2022 How fast COVID -19 spreads  \no Both the Pfizer and Moderna phase 3 clinical trials , which began before the end of July 2020 , \nincluded  30,000 -40,000 participants  (for comparison, picture how many people live in a mid -size \nsuburb) . Johnson & Johnson\u2019s phase 3 clinical trials began in September 2020 and included just over \n40,000 participants.   \no The clinical trials finished much more quickly than normal due to the quick spread of the virus and \nhigh infection rates. Usually in other vaccine trial s, there are so few infections it takes longer to see  \nif the vaccine works.  \n\u2022 Fast FDA review and vaccine production  \no The FDA review process for  vaccine safety and efficacy was thorough  and transparent. All of the data \nwas available online for the public.  \no Typically , vaccine manufacturing do es not begin  until receipt of FDA approval.  However, because of \nthe urgent need, the U.S. government ordered and paid for hundreds of millions of doses in advance .  \nThis meant that the  drug companies could ship  doses of va ccine as soon as authorized by the FDA.  \n  \n\u00bfC\u00f3mo se desarroll\u00f3 esta vacuna tan r\u00e1pidamente?  \nLa velocidad que permiti\u00f3 que esta vacuna se desarrollara y estuviera lista para su uso en menos de un a\u00f1o \nse debe a tres factores principales:  \n\u2022 El tipo de vacuna que se est\u00e1 usando  \n \nLas vacunas de ARNm (Pfizer y Moderna)  \no La secuencia gen\u00e9tica del virus estuvo ampliamente disponible en enero de 2020, lo que permiti\u00f3 a \nlos cient\u00edficos desarrollar vacunas r\u00e1pidamente. Se iniciaron los ensayos cl\u00ednicos de las va cunas en \netapa temprana incluso antes de que el virus alcanzara niveles pand\u00e9micos.  \no Otra ventaja de las vacunas de ARNm es que no existe la posibilidad de que puedan contener virus \nvivos.  \no As\u00ed funcionan las vacunas de ARNm: Cuando se inyecta, el ARNm le dic e al cuerpo c\u00f3mo producir \nuna prote\u00edna de pico que se encuentra en el exterior del virus. El cuerpo responde a esa prote\u00edna \ncomo un enemigo y se defiende produciendo anticuerpos. (Los anticuerpos son prote\u00ednas que se \nadhieren a prote\u00ednas en el exterior de los virus. Coordinan el esfuerzo para eliminar el virus del \ncuerpo). Entonces, las c\u00e9lulas del cuerpo recuerdan a ese enemigo y pueden producir esos \nanticuerpos en el futuro si los necesita.  \no La tecnolog\u00eda para producir vacunas de ARNm existe desde hace m\u00e1 s de 10 a\u00f1os.  \n \n  \n \n      Last Upda ted: 6/29/2021     8 \nPatient Return : Talking with Your \nPatients About COVID -19 Vaccines  \nLas vacunas de vectores virales (Johnson & Johnson)  \no La forma en que la vacuna de Johnson & Johnson le ense\u00f1a al cuerpo c\u00f3mo combatir el virus es \nsimilar a la vacuna de ARNm, pero tiene un punto de partida diferente. En lugar de inyectar ARNm \nya producido, esta vacuna hace que el cuerpo produzca el ARNm por s\u00ed solo.  \no Este tipo de vacuna agrega ADN de la prote\u00edna de pico de COVID -19 al ADN de doble hebra del \nvirus. Es un virus debilitado que no causar\u00e1 la enfermedad a quien reciba la vacuna.   \no El virus debilitado, que incluye el ADN de la prote\u00edna de pico, ing resa al centro de la c\u00e9lula, llamado \nn\u00facleo. La c\u00e9lula responde produciendo ARNm para la prote\u00edna de pico.  \no A partir de ah\u00ed, al igual que las otras vacunas COVID -19, la prote\u00edna de pico sale de la c\u00e9lula y \nestimula la respuesta inmune.  \n\u2022 \u00bfQu\u00e9 tan r\u00e1pido se p ropaga el COVID -19? \no Los ensayos cl\u00ednicos de fase 3 de Pfizer y Moderna, que comenzaron antes de finales de julio de \n2020, incluyeron entre 30,000 y 40,000 participantes (para comparar, imag\u00ednese la cantidad de \nhabitantes de un suburbio de tama\u00f1o mediano). Los ensayos cl\u00ednicos de fase 3 de Johnson & \nJohnson comenzaron en septiembre de 2020 e incluyeron a poco m\u00e1s de 40,000 participantes.  \no Los ensayos cl\u00ednicos terminaron mucho m\u00e1s r\u00e1pido de lo normal debido a la r\u00e1pida propagaci\u00f3n del \nvirus y las altas tasas de infecci\u00f3n. Por lo general, en otros ensayos de vacunas, hay tan pocas \ninfecciones que se necesita m\u00e1s tiempo para ver si la vacuna funciona.  \n\u2022 Revisi\u00f3n r\u00e1pida de la FDA y producci\u00f3n de vacunas  \no El proceso de revisi\u00f3n de la FDA para la seguridad y eficacia  de las vacunas fue completo y \ntransparente. Todos los datos estaban disponibles en l\u00ednea para el p\u00fablico.  \no Por lo general, la fabricaci\u00f3n de vacunas no comienza hasta que se recibe la aprobaci\u00f3n de la FDA. \nSin embargo, debido a la urgente necesidad, el gob ierno de los Estados Unidos orden\u00f3 y pag\u00f3 \ncientos de millones de dosis por adelantado.  Esto signific\u00f3 que las compa\u00f1\u00edas farmac\u00e9uticas \npodr\u00edan enviar dosis de vacuna tan pronto como lo autorizara la FDA.  \n \nIs the vaccine safe and effective?  \nAs a doctor of oral health, I look for reliable, research -based information when recommending treatments  \nfor my patients. While these vaccines were developed in a condensed time frame, the science behind them \nwas not rushed. They were tested in thousands of people  and the results have demonstrated that they are \nsafe for you and your family. The Food and Drug Administration (FDA) reviewed the data from the clinical \ntrials,  determin ed they were safe and effective  and granted Emergency Use Authorization for t heir use.  \nFor continuing  assurance of safe ty, the CDC has set up a safety monitoring system , the V-Safe smartphone \ntool, to receive information  from people who have gotten the vaccines  in real time.  \n  \n \n \n      Last Upda ted: 6/29/2021     9 \nPatient Return : Talking with Your \nPatients About COVID -19 Vaccines  \n\u00bfLa vacuna es segura y eficaz?  \nComo doctor en salud bucal, busco informaci\u00f3n confiable basada en investigaciones cuando recomiendo \ntratamientos para mis pacientes. Si bien estas vacunas se desarrollaron en un periodo condensado, la \nciencia detr\u00e1s de ellas no se apresur\u00f3. Se probaron en miles de personas y los resultados han demostrado \nque son seguras para usted y su familia. La Administraci\u00f3n de Alimentos y Medicamentos (FDA) revis\u00f3 los \ndatos de los ensayos cl\u00ednicos, d etermin\u00f3 que eran seguros y efectivos y otorg\u00f3 la Autorizaci\u00f3n de uso de \nemergencia para su uso.  \nPara garantizar la seguridad continua, el CDC ha establecido un sistema de monitoreo de seguridad, la \nherramienta para smartphone V -Safe, para recibir informaci\u00f3n de las personas que se han vacunado en \ntiempo real.  \n \nIs one vaccine better than another?  \nThere is no \u201cgood \u201d COVID -19 vaccine or \u201cbad\u201d COVID -19 vaccine. While there are differences in levels of \neffectiveness, all authorized vaccines will greatly reduce your risk of severe illness. And while vaccine supply \nis increasing, you might  not be able to choose which one you get. If you are able t o receive a vaccine, \nplease take what is available to you. The longer you wait, the higher your risk of getting sick.  \n \n\u00bfEs una vacuna mejor que otra?  \nNo existe una vacuna contra el COVID -19 \"buena\" ni una vacuna contra el COVID -19 \"mala\". Si bien \nexisten diferencias en los niveles de efectividad, todas las vacunas autorizadas reducir\u00e1n en gran medida \nsu riesgo de enfermedad grave. Y aunque el suministro de vacunas est\u00e1 aumentando, lo m\u00e1s probable es \nque no pueda elegir cu\u00e1l va a recibir. Si puede recibir u na vacuna, por favor acepte la que est\u00e9 disponible. \nCuanto m\u00e1s espere, mayor ser\u00e1 su riesgo de enfermarse.  \n \nCan I stop wearing a mask after I\u2019m vaccinated?  \nVaccines can help you resume the activities you enjoyed doing most before the pandemic. And once you\u2019re  \nfully vaccinated , you may be able to do them without a mask on .  In May 2021, the CDC said people who \nare fully vaccinated against COVID -19 can stop wearing masks in most places. You will still need a mask  \nin the following places:  \no Healthcare settings (like your dentist or doctor\u2019s office, a hospital or a nursing ho me)  \no Using public transportation  \no Transportation centers (like airports or train stations)  \no Local businesses and workplaces that require masks  \no Additional places where required by federal, state, local, tribal, or territorial laws,  \nrules, and regulations   \n \n \n      Last Upda ted: 6/29/2021     10 \nPatient Return : Talking with Your \nPatients About COVID -19 Vaccines  \n\u00bfNecesito usar cubre bocas si estoy completamente vacunado ? \nLas vacunas lo ayudar\u00e1n a regresar a las actividades que m\u00e1s disfrutaba antes de la pandemia.  \nY una vez que completamente vacunado , es posible que pueda hacerlo sin cubre bocas.  \nEn mayo de 2021, el CDC anunciaron que las personas que est\u00e9n completamente vacunadas contra  \nel COVID -19 pueden dejar de usar cubrebocas en la mayor\u00eda de los lugares. Tendr\u00e1 que s eguir usando \ncubrebocas en los siguientes lugares:  \no En entornos de atenci\u00f3n m\u00e9dica (como el consultorio de su dentista o m\u00e9dico, un hospital o  \nun hogar de ancianos)  \no Al usar transporte publico   \no En centros de transporte (como aeropuertos o estaciones de tr en)  \no En empresas y centros de trabajo locales que requieren cubrebocas  \no En otros lugares donde lo requieran las leyes, reglas y regulaciones federales, estatales,  \nlocales, tribales o territoriales  \n \nWill the vaccine give me COVID -19?  \nWhat other side effects should I be prepared for?  \nNo.  None  of the  COVID -19 vaccines with Emergency Use Authorization from  FDA can give you COVID -19.   \nHowever, after receiving the vaccine, you might experience side ef fects  such as fever, achiness or fatigue  \nfor a short time. This is because your body is learning how to fight off the virus . While this is not  pleasant,  \nit\u2019s actually a sign the vaccine is doing what it is supposed to do .  \n \nThere are very few (and extreme ly rare) , harmful events associated  with the vaccine , but people who have \nCOVID -19 itself may experience severe disease and increased risk of death. In addition, some people \nreferred to as \u201clong haulers \u201d have debilitating symptoms that can lasts months or may even be permanent.   \n \n\u00bfAl recibir la vacuna me enfermar\u00e9 de COVID -19?  \n\u00bfPara qu\u00e9 otros efectos secundarios debo estar preparado?  \nNo. Ninguna de las vacunas COVID -19 con autorizaci\u00f3n de uso de emergencia de la FDA pueden  \nprovocar que se enferme de COVID -19.   \nSin embargo, despu\u00e9s de recibir la vacuna, es posible que experimente efectos secundarios como fiebre, \ndolor o fatiga durante  un breve per\u00edodo. Esto se debe a que su cuerpo est\u00e1 aprendiendo a combatir el virus. \nSi bien esto no es agradable, en realidad es una se\u00f1al de que la vacuna est\u00e1 haciendo su trabajo.  \n \nExiste muy pocos eventos/datos donde el paciente ha sufrido efectos ex tremos  asociados a la vacuna, \npero las personas que tienen COVID -19 pueden experimentar de enfermedades sist\u00e9micas y tener un \n \n \n      Last Upda ted: 6/29/2021     11 \nPatient Return : Talking with Your \nPatients About COVID -19 Vaccines  \nmayor riesgo de muerte. Adem\u00e1s, algunas personas a las que se hace referencia como \"enfermos \nprolongados\" tienen s\u00edntomas debilit antes que pueden durar meses o incluso ser permanentes.   \n \nWill the COVID -19 vaccine change or enter my DNA?  \nmRNA vaccines , like Pfizer and Moderna,  do not  alter your DNA. The mRNA enters the cell but not the \nnucleus, where DNA is located. The machinery  of the cell that normally produces proteins uses the mRNA \nfrom the vaccine to produce  the spike protein of the virus before the mRNA itself is destroyed. The cells \nhave no use for this protein and spit it out , allowing it to be taken up by cells in the im mune system. These \ncells develop your body\u2019s response to the protein on the spot and also develop the memory so that your \nbody can response in the future.   \nJohnson & Johnson \u2019s vaccine does enter the nucleus of your cells , but it does not alter your DNA. It instead \nhelps your body produce mRNA, which travels to other cells and initiates your body\u2019s immune response.   \n \n\u00bfLa vacuna COVID -19 cambiar\u00e1 mi ADN o entrar\u00e1 en \u00e9l?  \nLas vacunas de ARNm, como Pfizer y Moderna, no altera n su ADN. El ARNm ingresa a la c\u00e9lula pero no  \nal n\u00facleo, donde se encuentra el ADN. La maquinaria de la c\u00e9lula que normalmente produce prote\u00ednas \nutiliza el ARNm de la vacuna para producir la prote\u00edna de pico del virus antes de que se destruya el ARNm \nmism o. A las c\u00e9lulas no les sirve esta prote\u00edna y la expulsan, lo que permite que las c\u00e9lulas del sistema \ninmunol\u00f3gico la absorban.  Estas c\u00e9lulas desarrollan la respuesta del cuerpo a la prote\u00edna en el momento  \ny tambi\u00e9n desarrollan la memoria para que el cue rpo pueda responder en el futuro.   \nLa vacuna de Johnson & Johnson ingresa al n\u00facleo de las c\u00e9lulas, pero no altera el ADN. En cambio,  \nayuda al cuerpo a producir ARNm, que viaja a otras c\u00e9lulas e inicia la respuesta inmune del cuerpo.   \n \nI get the flu s hot, and I still seem to get the flu every year.  \nWhy would the COVID -19 vaccine be any different?  \nWhile the typical flu vaccines are  40-50% effective , the two authorized vaccine s by Pfizer and Moderna,  \nare impressively 94 -95% effective.  That\u2019s twice as effective as the flu vaccine.   \nJohnson & Johnson \u2019s vaccine also  provide s strong protection against COVID -19. It is 66% percent  \neffective at preventing moderate to severe disease, 85% effective at preventing severe disease . There  \nwere no hospitalizations or deaths during Johnson & Johnson\u2019s clinical trials.   \n  \nMe pongo la vacuna contra la influenza y a\u00fan as\u00ed parece que me  \nda gripe todos los a\u00f1os. \u00bfPor qu\u00e9 la vacuna COVID -19 ser\u00eda diferente?  \nSi bien las vacunas t\u00edpicas contra la influenza tienen un 40 -50% de efectividad, las dos vacunas autorizadas \npor Pfizer y Moderna tienen un impresionante 94 -95% de efectividad. Eso es dos veces m\u00e1s eficaz que la \nvacuna contra la influenza.  \n \n \n      Last Upda ted: 6/29/2021     12 \nPatient Return : Talking with Your \nPatients About COVID -19 Vaccines  \nLa vacuna de Jo hnson & Johnson tambi\u00e9n proporciona una fuerte protecci\u00f3n contra COVID -19. Tiene una \neficacia del 66% en la prevenci\u00f3n de enfermedades de moderadas a graves y un 85% de eficacia en la \nprevenci\u00f3n de enfermedades graves. No hubo hospitalizaciones ni muertes durante los ensayos cl\u00ednicos  \nde Johnson & Johnson.  \n \nI\u2019m pretty healthy, so I doubt I\u2019ll get very sick if I do get COVID -19.  \nCan I skip the vaccine?  \nWhile  many people only have mild cases  of COVID -19, it is very likely they will infect others  because the \nvirus is highly contagious.  In addition, it is not possible to predict who will develop serious , or even lethal , \nCOVID -19 disease . In addition, some people with COVID -19 experience long -lasting symptoms t hat can be \nquite debilitating. And agai n, it is not possi ble to predict who will do so. The best way to protect your health  \nand the health of those around you  is to take all possible precautions, which includes being  vaccinated.  \n \nEstoy bastante sano, as\u00ed que dudo que me enferme mucho si  \ncontra igo COVID -19. \u00bfPuedo omitir la vacuna?  \nSi bien muchas personas solo tienen casos leves de COVID -19, es muy probable que infecten a otros \nporque el virus es altamente contagioso. Adem\u00e1s, no es posible predecir qui\u00e9n desarrollar\u00e1 la enfermedad \nCOVID -19 grav e o incluso letal. Adicionalmente, algunas personas con COVID -19 experimentan s\u00edntomas \nduraderos que pueden ser bastante debilitantes. Y, como ya dijimos, no es posible predecir qui\u00e9n se  \nver\u00e1 afectado. La mejor manera de proteger su salud y la salud de qu ienes lo rodean es tomar todas  \nlas precauciones posibles, lo que incluye vacunarse.  \n \nShould I still get vaccinated if I\u2019ve had COVID -19? \nPeople who have recovered from the virus have some natural immunity that may protect them from getting \nsick again, though some have been re-infected. We don\u2019t know how long natural immunity to COVID -19 \nlasts, and it can vary from person to person. So , the CDC recommends that people who\u2019ve had the virus  \nstill get the vaccine.  \n \n\u00bfDebo vacunarme si ya tuve COVID -19? \nLas personas que se han recuperado del virus tienen cierta inmunidad natural que puede protegerlos de \nenfermarse nuevamente, aunque algunas personas se han vuelto a infectar. No se sabe cu\u00e1nto dura la \ninmunidad natural al COVID -19 y puede variar de persona a persona. Por este motivo, los CDC \nrecomiendan que las personas que han tenido el virus tambi\u00e9n reciban la vacuna.  \n \n  \n \n \n      Last Upda ted: 6/29/2021     13 \nPatient Return : Talking with Your \nPatients About COVID -19 Vaccines  \nI\u2019ll have natural immunity if I get COVID -19. Isn\u2019t that more effective?  \nCOVID -19 can pose serious health risks for you and your loved ones. Being vaccinated poses no serious \nhealth risks to you or your loved ones.  \nNatural immunity happens when you get sick and your body builds up protection against that virus so you \ndon\u2019t get sick again \u2013 or as sick as you did the first time. With COVID -19, we don\u2019t know how long natural \nimmunity will last . And essentially, immunity after COVID -19 vaccination is natural immunity because it \ninvolves the exact same body response , without you first having to be sick.  \n   \nTendr\u00e9 inmunidad natural si contraigo COVID -19.  \n\u00bfNo es eso m\u00e1s efectivo?  \nEl COVID -19 puede representar graves riesgos de salud para usted y sus seres queridos. Estar vacunado \nno representa riesgos graves para la salud de usted ni de sus seres queridos.  \nLa inmunidad natural ocurre cuando usted se enferma y su cuerpo acumula protecci\u00f3n contra ese virus  \npara que no vuelva a enfermarse, o que no se enferme tanto como la primera vez. Con el COVID -19, no \nsabemos cu\u00e1nto durar\u00e1 la inmunidad natural. Y esencialmen te, la inmunidad despu\u00e9s de la vacunaci\u00f3n \ncontra COVID -19 es inmunidad natural porque implica exactamente la misma respuesta corporal,  \nsin que primero tenga que estar enfermo.  \n \nHow many doses do I need ?  \nIf you are receiving the Pfizer or Moderna mRNA v accines, you need two doses t o get the same level  \nof efficacy seen in the clinical trials , which was 94 -95%. For the Pfizer vaccine, the second dose is \nrecommend ed three weeks after the first.  For the Moderna  vaccine, the second dose is recommended  \nfour weeks after the first.   \nThe Johnson & Johnson vaccine only requires one dose.  \n \n\u00bfCu\u00e1ntas dosis necesito?   \nSi va a recibir las vacunas de ARNm de Pfizer o Moderna, necesita dos dosis para obtener el mismo nivel  \nde eficacia observado en los ensayos cl\u00ednicos, que fue del 94 -95%. Para la vacuna de Pfizer, se \nrecomienda la segunda dosis tres semanas despu\u00e9s de la primera. Para la vacuna de Moderna, se \nrecomienda la segunda dosis cuatro semanas despu\u00e9s de la primera.    \nLa vacuna de Johnson & Johnson solo requiere una dosis.  \n \n  \n \n \n      Last Upda ted: 6/29/2021     14 \nPatient Return : Talking with Your \nPatients About COVID -19 Vaccines  \nI\u2019m pregnant (or planning to be). Is it safe to get vaccinated?  \nWhether you are pregnant now or planning to get pregnant in the future, you should get the vaccine when  \nyou can . The CDC state s there is no evidence that the COVID -19 vaccines will cause any problems with \npregnancy. The re is also no evidence that fertility issues will result from this vaccine (or any other vaccine.) \nAsk us for a copy of the special fact sheet that offers more information on COVID -19 vaccines, pregnancy \nand breastfeeding. If you still have questions or uncertainties  please talk with your OB/GYN about  \nyour concerns.  \n \nEstoy embarazada (o planeo estarlo). \u00bfEs seguro vacunarme?  \nSi est\u00e1 embarazada ahora o planea quedar embarazada en el futuro, debe vacunarse cuando pueda. Los \nCDC afirman que no hay evidencia de que las vacunas contra COVID -19 causen alg\u00fan problema con el \nembarazo. Tampoco hay evidencia de que esta vacuna (o cualquier otra vacuna) produzca problemas de \nfertilidad. P\u00eddanos una copia de la hoja de datos especial que ofrece m\u00e1s informaci\u00f3n sobre las vacunas \nCOVID -19, el embarazo y la lactancia. Si a\u00fan tiene preguntas o dudas, hable con su obstetra / ginec\u00f3logo \nsobre sus inquietudes.  \n \nShould I worry about reactions to the COVID -19 vaccine?  \nSerious reactions to the COVID -19 vaccines are exceedingly rare. One that has caused some concern is \nanaphylaxis (allergic reactions). There have been a very small number of allergic reactions reported, but \nagain, these are very rare cases. The CDC recommends anyone with a history of severe allergic reactions \nwhen being vac cinated in the past \u2014 or to any of the ingredients in the vaccine \u2014 talk with healthcare \nproviders before being vaccinated. The ingredients for the vaccine are listed on FDA fact sheets:  \no Pfizer  \no Moderna  \no Johnson & Johnson  \nTo guard against unexpected serious allergic reacti ons, you will be asked about any allergies before you \nreceive your vaccine and asked to stay for an additional 15 -30 minutes after receiving the vaccine.  \nAnother side effect that has caused some concern is the risk of blood clots. Out of an abundance of c aution, \nthe FDA put the J&J on a pause in April 2021 while it investigated reports. After looking at all the \ninformation, the FDA and CDC found it safe to resume using the vaccine.  \nWhile no medical treatment is completely risk -free, the information we have  suggests the risk of developing \nthis side effect is less than one in a million. You can learn more on the Johnson & Johnson vaccine fact \nsheet , and please talk with your healthcare provider if you have additional questions.  \n \n  \n \n \n      Last Upda ted: 6/29/2021     15 \nPatient Return : Talking with Your \nPatients About COVID -19 Vaccines  \n\u00bfDebo preocuparme por las reacciones al\u00e9rgicas a la vacuna  \ncontra COVID -19? \nLas reacciones graves a las vacunas contra el COVID -19 son extremadamente inusuales. Una reacci\u00f3n \nque ocasion\u00f3 cierta inquietud es la anafilaxis (reacciones al\u00e9rgicas). Ha habido una peque\u00f1a cantidad de \nreacciones al\u00e9rgicas que se han informado, pero, como se dijo anteriormente, se trata de casos muy \ninusuales. Los CDC recomiendan que toda persona que haya tenido reacciones al\u00e9rgicas graves a \ncualq uiera de los ingredientes de la vacuna al vacunarse anteriormente hable con los proveedores de \natenci\u00f3n m\u00e9dica antes de vacunarse. Los ingredientes de la vacuna se indican en las hojas de datos  \nde la FDA:  \no Pfizer  \no Moderna  \no Johnson & Johnson  \nPara protegerse contra las re acciones al\u00e9rgicas graves e inesperadas es muy importante contestar a la \npregunta que se le har\u00e1 referente a sus alergias existentes antes de recibir la vacuna y se le pedir\u00e1 que se \nquede de 15 a 30 minutos despu\u00e9s de la aplicaci\u00f3n asegurar se encuentre bi en.  \nOtro efecto secundario que ha ocasionado inquietud es el riesgo de co\u00e1gulos sangu\u00edneos. Por precauci\u00f3n, \nla FDA puso en pausa la vacuna de J&J en abril de 2021 mientras investigaba los reportes. Despu\u00e9s de \nanalizar toda la informaci\u00f3n, la FDA y los CDC  determinaron que es seguro continuar usando la vacuna.  \nAunque ning\u00fan tratamiento m\u00e9dico es completamente libre de riesgos, la informaci\u00f3n que tenemos sugiere \nque el riesgo de desarrollar este efecto secundario es de menos de uno en un mill\u00f3n. Puede obtene r m\u00e1s \ninformaci\u00f3n en la hoja de datos de la vacuna Johnson & Johnson . Hable con su proveedor de atenci\u00f3n \nm\u00e9dica si tiene m\u00e1s preg untas.  \n \nCan my child be vaccinated?  \nHelping family members get the COVID -19 vaccine protects your loved ones and helps us all start to return \nto normal.  When it comes to children, vaccination eligibility varies by age:   \no If your child is 18 or older, they can receive any of the currently available vaccines.  \no If your child is 12 -17, they can receive the Pfizer vaccine.  \no If your child is younger than 12, they  are not currently eligible to be vaccinated.  \nHowever, clinical trials are underway for younger children.  \n \n  \n \n \n      Last Upda ted: 6/29/2021     16 \nPatient Return : Talking with Your \nPatients About COVID -19 Vaccines  \n\u00bfSe puede vacunar mi hijo?  \nAyudar a los miembros de la familia a recibir la vacuna contra el COVID -19 es importante para as\u00ed proteger \na nuestros seres queridos y contribuir para regresar a la normalidad.  \nLa elegibilidad para la vacunaci\u00f3n var\u00eda seg\u00fan la edad:   \no Si su hijo tiene 18 a\u00f1os o m\u00e1s, puede recibir cualquiera de las vacunas disponibles actualmente.  \no Si su hijo tiene entre 12 y 17 a\u00f1os, puede recibir la vacuna de Pfizer.  \no Si su hijo es menor de 12 a\u00f1os, actualmente no es elegible para vacunarse. Sin embargo, se est\u00e1n \nrealizando ensayos cl\u00ednicos para ni\u00f1os m\u00e1s peque\u00f1os.  \n \nIs the vaccine safe and effect ive for children?  \nThe Pfizer vaccine is the only COVID -19 vaccine currently authorized for use in Americans 12 to 18 years  \nof age. Pfizer clinical trial data shows the vaccine is 100% effective in adolescents and that vaccine side \neffects in children are similar to those experienced by adults. Children and adults receive the same dosage \nof the Pfizer vaccine, administered as a series of two doses, three weeks apart.   \nTalk to your healthcare provider or pediatrician if you have questions about the COVID -19 vaccine and  \nyour child.  \n \n\u00bfLa vacuna es segura y eficaz para los ni\u00f1os?  \nLa vacuna Pfizer es la \u00fanica vacuna contra el COVID -19 actualmente autorizada para su uso en los \nestados unidos de 12 a 18 a\u00f1os de edad. Los datos de los ensayos cl\u00ednicos de Pfizer m uestran que  \nla vacuna es 100% efectiva en adolescentes y que los efectos secundarios de la vacuna en los ni\u00f1os  \nson similares a los que experimentan los adultos. Los ni\u00f1os y los adultos reciben la misma dosis de la \nvacuna Pfizer, administrada en una serie  de dos dosis, con tres semanas de diferencia.   \nHable con su proveedores de atenci\u00f3n m\u00e9dica o pediatra si tiene preguntas sobre la vacuna contra  \nel COVID -19 y su hijo.  \n \nI want to get vaccinated, but I don\u2019t know where to go.  \nThe CDC created easy -to-use tools to help you find a vaccine nearby:  \no Visit Vaccines.gov  to search by vaccine type and zip code.  \no Text GETVAX (438829) for English or VACUNA (822862) for Spanish to receive vaccine sites  \non your phone.  \no Call the National COVID -19 Vaccination Assistance Hotline at 800.232.0233.  \n \n \n \n      Last Upda ted: 6/29/2021     17 \nPatient Return : Talking with Your \nPatients About COVID -19 Vaccines  \nQuiero vacunarme, pero no s\u00e9 ad\u00f3nde ir.  \nEl CDC han creado herramientas f\u00e1ci les de usar para ayudarle a encontrar una vacuna cerca:  \no Visite Vacunas.gov  para buscar por tipo de vacuna y c\u00f3digo postal.  \no Env\u00ede un mensaje de texto a GETVAX (438829) para ingl\u00e9s o VACUNA (822862) para espa\u00f1ol  \npara recibir sitios de vacunas en su tel\u00e9fono.  \no Llame a la L\u00ednea Directa Nacional de Asistencia para la Vacunaci\u00f3n contra el COVID -19 al  \n800.232.0233.  \n \nCan I get the COVID -19 vaccine while I\u2019m getting other vaccines I need?  \nYes, you can get a dose of the COVID -19 vaccine and other vaccines in the same visit or without a \u201cwaiting \nperiod\u201d between vaccines of different types. Talk with your healthcare provider if you have any questions \nabout your vaccine schedule.  \n  \n \n\u00bfPuedo recibir la vacuna COVID -19 mientras  recibo otras vacunas que \nnecesito?  \nS\u00ed, puede recibir una dosis de la vacuna COVID -19 y otras vacunas en la misma visita o sin un \u201cperiodo de \nespera\u201d entre vacunas de diferentes tipos. Hable con su proveedor de atenci\u00f3n m\u00e9dica si tiene alguna \npregunta sobr e su programa de vacunaci\u00f3n.  \n \n  \n \n \n      Last Upda ted: 6/29/2021     18 \nPatient Return : Talking with Your \nPatients About COVID -19 Vaccines  \nEmail  #1: Your Own Vaccination Experience  \n \nSubject : Why I Decided to Get the COVID -19 Vaccine  \nPre-header : Reasons I encourage you to think about getting vaccinated, too  \n \nDear [Patient Name] : \nWhat have you heard about vaccination for COVID -19? I know there\u2019s been plenty of talk about the benefits and \npossible risks, and many people aren\u2019t sure whether they will get the vaccine just yet.   \nSince I care a great deal about your oral and overall he alth, I wanted to share my own personal experiences with you. \nWe\u2019re all in this together, and I feel an open dialogue is helpful to everyone.  \nI received my first vaccine shot recently, and I\u2019m happy to say it went well.  [Include a few details, such as how  \nyou booked your appointment, the hospital or clinic you visited, a word or two about the efficiency or friendliness of \nthe medical staff, and whether or not you felt any mild side effects afterward].  \nIn truth, it was easy for me to say \u201cyes\u201d to the vacci ne. This is because I\u2019ve studied the current science, which shows  \nthese vaccines are safe and effective  nearly everyone . Of course, if you have medical concerns, please consult your \nphysician.  \nAll of us at [Practice Name]  are committed to your good health . That\u2019s why we\u2019re wearing special protective \nequipment, are even more scrupulous about keeping our office and exam rooms spotlessly clean  and disinfected  and \nare requiring masks for all patients and visitors.  \n \nIn my view, getting vaccinated is just one m ore way we can protect ourselves and each other.  \nI realize you may want to know more about COVID -19 vaccines and your health. I will be happy to address \nany questions you have . We also have fact sheets that may be helpful to you. Pick one up when you come  in, or \nask our staff to email a copy to you.  \nLooking forward to seeing you in our office soon!  \n \n[Your Name]  \n[Practice Name]  \n   \n \n      Last Upda ted: 6/29/2021     19 \nPatient Return : Talking with Your \nPatients About COVID -19 Vaccines  \nCorreo electr\u00f3nico N.\u00ba 1: Su propia experiencia de vacunaci\u00f3n  \n \nAsunto : Por qu\u00e9 decid\u00ed ponerme la vacuna contra COVID -19 \nPre enca bezado : Razones por las que le invito a que piense en vacunarse tambi\u00e9n  \n \nEstimado/a [nombre del paciente] : \n\u00bfQu\u00e9 ha escuchado sobre la vacunaci\u00f3n contra el COVID -19? S\u00e9 que se ha hablado mucho sobre los beneficios y \nlos posibles riesgos, y muchas personas no est\u00e1n seguras de si recibir\u00e1n la vacuna todav\u00eda.   \nDado que me interesa mucho su salud oral y su salud en  general, quise compartir mis propias experiencias \npersonales con usted. Todos estamos juntos en esto y creo que un di\u00e1logo abierto es \u00fatil para todos.  \nRecib\u00ed mi primera vacuna recientemente y me complace decir que sali\u00f3 bien.  [Incluya algunos detalles, como la \nmanera en que hizo su cita, el hospital o la cl\u00ednica que visit\u00f3, un breve mensaje sobre la eficiencia o amabilidad del \npersonal m\u00e9dico y si tuvo o no alg\u00fan efecto secundario leve despu\u00e9s].  \nEn verdad, fue f\u00e1cil para m\u00ed de cidirme a vacunarme. Esto se debe a que he estudiado la ciencia actual, que muestra \nque estas vacunas son seguras y efectivas para casi todo el mundo. Por supuesto, si tiene inquietudes m\u00e9dicas, \nconsulte a su m\u00e9dico.  \nTodos nosotros en [nombre del consulto rio] estamos comprometidos con su buena salud. Es por eso que llevamos \nequipo de protecci\u00f3n especial, somos a\u00fan m\u00e1s escrupulosos en mantener nuestro consultorio y salas de exploraci\u00f3n \nimpecablemente limpios y desinfectados y exigimos cubrebocas para todos los pacientes y visitantes.  \n \nEn mi opini\u00f3n, vacunarnos es solo una forma m\u00e1s de protegernos a nosotros mismos y a los dem\u00e1s.  \nS\u00e9 que es posible que desee saber m\u00e1s sobre las vacunas contra el COVID -19 y su salud. Con gusto \nresponder\u00e9 a cualquier duda que tenga . Tambi\u00e9n tenemos hojas informativas que pueden resultarle \u00fatiles. Tome \nuna cuando llegue o p\u00eddale a nuestro personal que le env\u00ede una copia por correo electr\u00f3nico.  \n\u00a1Esperamos verle en nuestro consultorio pr\u00f3ximamente!  \n \n[Su nombre]  \n[Nombre del consul torio]  \n \n   \n \n      Last Upda ted: 6/29/2021     20 \nPatient Return : Talking with Your \nPatients About COVID -19 Vaccines  \nEmail  #2: Opening the Vaccine Conversation  \n \nSubject : Talking About the COVID -19 Vaccine at Your Next Dental Visit  \nPre-header : We\u2019re here to help you make an informed decision about getting vaccinated  \n  \nDear [Patient Name] :  \nAs a doctor of oral health, I care about much more than your smile. My goal is to support your total well -being, and \nthat includes helping you consider what steps to take in protecting yourself from COVID -19.  \nThis is why I plan to ask you what you\u2019ve hear d about the COVID -19 vaccine and if you\u2019ve received it at your next \ndental visit. The pandemic has affected all of us. Prevention is crucial if we\u2019re going to stop the virus from spreading \nhere at home and across the country.  \n[If you have received the vac cine, consider adding the following paragraph]  I\u2019ve already gotten the vaccine \nbecause I believe it is a wise and effective step . My decision is based on the scientific studies I\u2019ve read and the \nguidance coming from the U.S. Centers for Disease Control and  Prevention (CDC) and others.  \nStill, I realize you may have many concerns.  So I\u2019ll be asking for your thoughts when I see you and offering to \nanswer any questions about vaccination that you may have. My staff will also be happy to email you fact sheets to  \nhelp inform your decision.  \nI look forward to your next dental visit. As always, you can continue to expect our strict health and safety protocols  \nto be in place, including keeping our office and exam rooms spotlessly clean  and disinfected , continued use of \nenhanced personal protective equipment  (like masks, face shields and gowns)  and screening questions before your \nvisit begins.  \n \n[Your Name]  \n[Practice Name]  \n   \n \n      Last Upda ted: 6/29/2021     21 \nPatient Return : Talking with Your \nPatients About COVID -19 Vaccines  \nCorreo electr\u00f3nico N.\u00ba 2: Iniciar la conversaci\u00f3n sobre las vacunas  \n \nAsunto : Hablar sobre la vacuna contra el COVID -19 en su pr\u00f3xima visita dental  \nPre encabezado : Estamos aqu\u00ed para ayudarle a tomar una decisi\u00f3n informada sobre la vacunaci\u00f3n.  \n  \nEstimado/a [nombre del paciente] :  \nComo m\u00e9dico de salud bucal, me interesa mucho m\u00e1s que su sonrisa. Mi o bjetivo es apoyar su bienestar total, y eso \nincluye ayudarlo a considerar qu\u00e9 pasos tomar para protegerse delCOVID -19.  \nEs por eso que en su pr\u00f3xima consulta dental planeo preguntarle qu\u00e9 ha escuchado sobre la vacuna contra el \nCOVID -19 y si la ha recibido.  La pandemia nos ha afectado a todos. La prevenci\u00f3n es crucial para evitar que el virus \nse propague aqu\u00ed en casa y en todo el pa\u00eds.  \n[Si usted ya recibi\u00f3 la vacuna, considere agregar el siguiente p\u00e1rrafo]  Yo ya me puse la vacuna porque creo \nque es un paso sensato y eficaz. . Mi decisi\u00f3n se basa en los estudios cient\u00edficos que he le\u00eddo y en la orientaci\u00f3n de \nlos Centros para el Control y la Prevenci\u00f3n de Enfermedades (CDC) de EE. UU. y otras fuentes.  \nA\u00fan as\u00ed, s\u00e9 que puede tener muchas inquietudes.  As\u00ed que le  preguntar\u00e9 qu\u00e9 piensa cuando lo vea y me ofrecer\u00e9 \na responder cualquier pregunta que pueda tener sobre la vacunaci\u00f3n. Mi personal tambi\u00e9n puede enviarle hojas \ninformativas por correo electr\u00f3nico para ayudarle a informar su decisi\u00f3n.  \nLe espero en su pr\u00f3xim a consulta dental. Como siempre, puede seguir esperando que se implementen nuestros \nestrictos protocolos de salud y seguridad, que incluyen mantener nuestro consultorio y salas de exploraci\u00f3n \nimpecablemente limpios y desinfectados, el uso continuo de equip o de protecci\u00f3n personal mejorado (como \ncubrebocas, protectores faciales y batas) y preguntas filtro antes de que comience su consulta.  \n \n[Su nombre]  \n[Nombre del consultorio]  \n \n   \n \n      Last Upda ted: 6/29/2021     22 \nPatient Return : Talking with Your \nPatients About COVID -19 Vaccines  \nEmail #3: Opening Where  to Find the COVID -19 Vaccine  \n \nSubject : Wondering Where to Get Vaccinated for COVID -19?  \nPre-header : Here\u2019s where you can find the vaccine in our area  \n  \nDear [Patient Name] : \nWe\u2019ve had many conversations in recent days about getting vaccinated for COVID -19. In case you\u2019re wondering how \nand where to find the vaccine, I wanted to share some helpful information with you.  \nIn our area, COVID -19 vaccines are being given at:  \n\u2022 List hospitals, clinics or pharmacies offering vaccines.  \n\u2022 Big box businesses (such as grocery stores)  \n\u2022 Larger venues set up specifically for this purpose such as football stadiums  \n\u2022 Include address, phone, and hours of operation wherever possible.  \n\u2022 If there are local hotlines or services helping people get appointments, include them too.  \nIf you\u2019re still uncertain about vaccination, we are happy to answer any questions you may have.  My dental \nteam can email you helpful fact sheets that cover the latest research on vaccine safety and effectiveness.  \nWe know that the pandemic has caused a great de al of stress for everyone. Please know that we are concerned \nabout your health and committed to doing all we can to protect you and your family, now and in the future.  \nHope to see you in person soon!  \n \n[Your Name]  \n[Practice Name]  \n   \n \n      Last Upda ted: 6/29/2021     23 \nPatient Return : Talking with Your \nPatients About COVID -19 Vaccines  \nCorreo electr\u00f3nico N.\u00ba 3: Inicio para d\u00f3nde encontrar la vacuna contra el \nCOVID -19  \n \nAsunto : \u00bfSe pregunta d\u00f3nde vacunarse contra el COVID -19?  \nPre encabezado : Estos son los lugares donde puede encontrar la vacuna en nuestra \u00e1rea.  \n  \nEstimado/a [nombre del paciente] : \nHemos tenido muchas conversaciones en los \u00faltimos d\u00edas sobre la vacunaci\u00f3n contra el COVID -19. En caso de que \nse est\u00e9 preguntando c\u00f3mo y d\u00f3nde encontrar la vacuna, quise compartir informaci\u00f3n \u00fatil con usted.  \nEn nuestra \u00e1rea, las vacunas contra el COVID -19 se administran en:  \n\u2022 Enumere los hospitales, cl\u00ednicas o farmacias que ofrecen vacunas.  \n\u2022 Grandes empresas (como supermercados)  \n\u2022 Lugares m\u00e1s grandes adaptados espec\u00edficamente para este prop\u00f3sito, como estadios de f\u00fatbol.  \n\u2022 Incluya la direcci\u00f3n, el tel\u00e9fono y el horar io de atenci\u00f3n siempre que sea posible.  \n\u2022 Si hay l\u00edneas directas o servicios locales que ayuden a las personas a obtener citas, incl\u00fayalas tambi\u00e9n.  \nSi a\u00fan no est\u00e1 seguro acerca de la vacunaci\u00f3n, con gusto responderemos cualquier pregunta que pueda \ntener.  Mi equipo dental puede enviarle por correo electr\u00f3nico hojas informativas \u00fatiles que cubren las \u00faltimas \ninvestigaciones sobre la seguridad y eficacia de las vacunas.  \nSabemos que la pandemia ha causado mucho estr\u00e9s a todos. Tenga en cuenta que nos preocupa su salud y \nestamos comprometidos a hacer todo lo posible para protegerlo a usted y a su familia, ahora y en el futuro.  \n\u00a1Esperamos verle en persona pronto!  \n \n[Su nomb re] \n[Nombre del consultorio]  \n \n   \n \n      Last Upda ted: 6/29/2021     24 \nPatient Return : Talking with Your \nPatients About COVID -19 Vaccines  \nIn-Office Signs  \nHere are five signs  with helpful tips about COVI D-19 vaccines. Complete customizable fields  (on signs where \ncustomization is available) , print and display them in waiting areas, exam rooms and other areas.  \n \n \nDOWNLOAD:   \nADA Vaccine Questions  (English)  \nADA Vaccine Questions ( Spanish ) \n  \nDOWNLOAD  & CUSTOMIZE :  \nADA Ready for Vaccine (English)  \nADA Ready for Vaccine ( Spanish ) \n  \n \n \n \n \n \nDOWNLOAD  & CUSTOMIZE :  \nADA I Got Vaccinated (English)  \nADA I Got Vaccinated ( Span ish) \n \n \n \nDOWNLOAD:   \nADA Vaccination Thank You (English)  \nADA Vaccination Thank You ( Spanish )  \nDOWNLOAD:   \nADA Vaccine Did You Know (English)  \nADA Vaccine Did You Know (Spanish)  \n  \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n      Last Upda ted: 6/29/2021     25 \nPatient Return : Talking with Your \nPatients About COVID -19 Vaccines  \n  Suggestions for Social Media  \n  Here are tips you can use to create simple messages for sharing on Facebook and other platforms.  \n \nDO: \no Share resources from trusted health organizations. The ADA social channels will have posts about \nthe vaccine. The CDC\u2019s website  also has social media text and images you can use.  \no Use your personal vaccination experience to educate, not advertise. Share why you decided to get \nthe COVID -19 vaccine and consider sharing any information including the vaccine process or side \neffects you think would help support this teachable moment.  \no Emphasize that vaccines are another layer of protection against the virus, one that supports the \nsafety protocols you and yo ur dental team are already following.  \no Continue to discuss the ways your entire team are working to keep them safe with the enhanced \nprotocols that have been in place since offices reopened. An additional toolkit of materials on what to \nexpect at dental vis its is available at ADA.org/ Patient Return . \no Be positive and empathetic. Acknowledge that people may have doubts about vaccinat ion, and \neveryone should have access to the facts about safety and effectiveness.  \no If you believe a user has shared what you believe to be harmful content, false information or spam, \neach platform has options for hiding or deleting comments that are posted  to your page. You can also \nreport the comment to the platform for review.  \no Share links and contact information for your nearest public health department to provide more \ninformation  \nand help connect people with vaccination opportunities.  \n \nDON\u2019T:  \no Share inf ormation from questionable sources or other people\u2019s personal posts.  \no Post a copy of your vaccination card. The Better Business Bureau  cautions  this may  inadvertently \nshare personal data.  \no Criticize those who feel hesitant about vaccines. Some people have m edical conditions or religious or \nphilosophical beliefs that might prevent them from taking this step. Others may simply have questions \nthey need answered  before making their decision.  \no Disclose your team\u2019s over all vaccination status or rate, or s hare a team member\u2019s vaccination stories  \nunless you have express permission to do so.  \n \n \n \n \n \n      Last Upda ted: 6/29/2021     26 \nPatient Return : Talking with Your \nPatients About COVID -19 Vaccines  \nAdditional COVID -19 Vaccine Resources  \nUse the links below to help continue educating your patients about COVID -19 vaccines.  \nAd Council  \no COVID -19 Vaccine Education Campaign: \"It's Up to You\"  \nAmerican College of Obstetricians and Gynecologists  \no Vaccinating Pregnant and Lactating Patients Against COVID -19 Practice Advisory  \nAmerican College of Allergy, Asthma and Immunology  \no ACAAI Provides Further Guidance on Risk of Allergic Reactions to mRNA COVID -19 Vaccines  \nAmerican Dental Association  \no Patient resource: \u201cCOVID -19 Vaccines: 7 Things Your Dentist Wants You to Know\u201d  \no Professional resources: COVID -19 Vaccine Information and Resources  \no Recorded webinar: \"Let's Talk Shots! Effective Patient Conversations About the COVID -19 Vaccine  \no Recorded webinar: \"Oh Baby! CO VID-19 Factos on Pregnancy and Fertility\" with  \nOB-GYN Dr. Geeta K. Swamy  \no White Paper: The Ethics of Vaccination  \nCenters for Disease Control and Pre vention  \no CDC COVID -19 Vaccination   \no COVID -19 Vaccination Communication Toolkit   \no Talking to Recipients about COVID -19 Vaccines   \no Understanding and Explaining mRNA COVID -19 Vaccines   \no Answering Patients\u2019 Questions   \no Continuing the Journey of a COVID -19 Vaccine   \no COVID -19 Advisory Committee on Immunization Practices (ACIP) Vaccine Recommendations  \nNational Institutes of Health  \no NIH COVID -19 Vaccine Resources   \no A Communicator\u2019s Tip Sheet for COVID -19 Vaccination   \nU.S. Department of Health and Human Services  \no COVID -19 Community Corps public awareness campaign materials for individuals and  \nhealth care providers  ", "language": "PDF", "image": "PDF", "pagetype": "PDF", "links": "PDF"}